Project

Cilengitide for subjects with newly diagnosed glioblastoma multiforme and methylated MGMT gene promotor - a multicenter, open-label, controlled phase III study, testing cilengitide in combination with standard treatment (temozolomide with concomitant radiation therapy, followed by temozolomide maintenance therapy) versus standard treatment (CENTRIC)

Completed · 2009 until 2013

RSS